Covered recipient · General Payments record
RALPH HODGES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018
$162.30
- Reported across 11 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $162.30 | 11 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $52.79 | 3 |
| Allergan Inc. | $32.23 | 2 |
| Amgen Inc. | $23.27 | 2 |
| AMAG Pharmaceuticals, Inc. | $14.84 | 1 |
| Regeneron Healthcare Solutions, Inc. | $13.57 | 1 |
| EISAI INC. | $13.36 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $12.24 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $162.30 | 11 |
Payment records · PY2018 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Allergan Inc. | $12.38 | 02/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 596656871 | CMS |
| Allergan Inc. | $19.85 | 04/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | 596656883 | CMS |
| AMAG Pharmaceuticals, Inc. | $14.84 | 06/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559467847 | CMS |
| Amgen Inc. | $11.03 | 05/29/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567902169 | CMS |
| Amgen Inc. | $12.24 | 06/04/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567902171 | CMS |
| Eisai Inc. | $13.36 | 03/27/2018 | Food and Beverage | Undisputed | 01/23/2026 | 603793679 | CMS |
| Novartis Pharmaceuticals Corporation | $12.24 | 01/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 608251833 | CMS |
| Novo Nordisk Inc | $19.25 | 03/17/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587918147 | CMS |
| Novo Nordisk Inc | $10.57 | 05/15/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587918153 | CMS |
| Novo Nordisk Inc | $22.97 | 06/12/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587918149 | CMS |
| Regeneron Healthcare Solutions, Inc. | $13.57 | 06/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | 570213343 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.